Evidence map›Paper›PMID 40396259›Full record

ArticleJournal of investigative medicine high impact case reports

Recurrent DVT and Mediastinal Adenopathy: A Silent Manifestation of Gallbladder Cancer.

Zakaria Alagha, Tata Avalishvili, Samuel Crow, Samhitha Gundakaram, Thomas McIntosh, Muhammad Ghallab, Yousef Shweihat, Bisher Mustafa, Amro Al-Astal, Ahmed Mahdi

Abstract readCase Reports
In one paragraph

Article in Journal of investigative medicine high impact case reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zakaria AlaghaInternal Medicine Department, Joan Edwards School of Medicine, Huntington, WV, USA.ORCID 0009-0002-1092-3565
Tata AvalishviliInternal Medicine Department, Joan Edwards School of Medicine, Huntington, WV, USA.
Samuel CrowInternal Medicine Department, Joan Edwards School of Medicine, Huntington, WV, USA.
Samhitha GundakaramInternal Medicine Department, Joan Edwards School of Medicine, Huntington, WV, USA.
Thomas McIntoshInternal Medicine Department, Joan Edwards School of Medicine, Huntington, WV, USA.
Muhammad GhallabCreighton University, Omaha, NE, USA.
Yousef ShweihatPulmonary and Critical Care Medicine Department, Joan Edwards School of Medicine, Huntington, WV, USA.ORCID 0000-0003-2174-9785
Bisher MustafaInternal Medicine Department, Joan Edwards School of Medicine, Huntington, WV, USA.
Amro Al-AstalPulmonary and Critical Care Medicine Department, Joan Edwards School of Medicine, Huntington, WV, USA.
Ahmed MahdiInternal Medicine Department, Joan Edwards School of Medicine, Huntington, WV, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recurrent deep vein thrombosis (DVT) is a common complication, particularly in cancer patients. We present a case of a 50-year-old male with a history of a previous DVT. Despite therapeutic anticoagulation with apixaban, the patient developed recurrent DVT involving the common femoral, popliteal, and foreleg veins. He was started on a heparin drip in the hospital, but despite this, his DVT worsened. Imaging studies revealed mediastinal and hilar lymphadenopathy, raising suspicion of malignancy. The workup revealed elevated tumor markers, while the thrombophilia panel was unremarkable. Despite aggressive management, including mechanical thrombectomy, catheter-directed thrombolysis, and the placement of an inferior vena cava filter, the patient's condition continued to deteriorate. A biopsy of the mediastinal lymph nodes revealed poorly differentiated mucinous adenocarcinoma with molecular analysis consistent with hepatobiliary origin, and the patient was diagnosed with stage IVB gallbladder cancer. Given the rarity of gallbladder cancer and its association with hypercoagulability, this case highlights the importance of considering cancer as an underlying cause of recurrent DVT after ruling out common causes. Early recognition and a comprehensive diagnostic approach are essential for managing such cases. The patient was started on chemotherapy while maintaining anticoagulation for recurrent DVT.

Indexed as

Adenocarcinoma, MucinousGallbladder NeoplasmsLymphadenopathyVenous ThrombosisAnticoagulantsHumansMaleMiddle AgedRecurrenceAnticoagulantsadenocarcinomadeep vein thrombosisgallbladder cancerhypercoagulabilitymalignancy

Identifiers

PMID40396259
PMCPMC12099096

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.